230 related articles for article (PubMed ID: 20053993)
1. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
Jiao X; Katiyar S; Willmarth NE; Liu M; Ma X; Flomenberg N; Lisanti MP; Pestell RG
J Biol Chem; 2010 Mar; 285(11):8218-26. PubMed ID: 20053993
[TBL] [Abstract][Full Text] [Related]
2. Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor.
Katiyar S; Jiao X; Wagner E; Lisanti MP; Pestell RG
Mol Cell Biol; 2007 Feb; 27(4):1356-69. PubMed ID: 17145782
[TBL] [Abstract][Full Text] [Related]
3. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
4. Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.
Shen Q; Uray IP; Li Y; Zhang Y; Hill J; Xu XC; Young MR; Gunther EJ; Hilsenbeck SG; Colburn NH; Chodosh LA; Brown PH
Cancer Prev Res (Phila); 2008 Jun; 1(1):45-55. PubMed ID: 19138935
[TBL] [Abstract][Full Text] [Related]
5. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
6. A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.
Ngan E; Northey JJ; Brown CM; Ursini-Siegel J; Siegel PM
J Cell Sci; 2013 May; 126(Pt 9):1981-91. PubMed ID: 23447672
[TBL] [Abstract][Full Text] [Related]
7. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
Turpin J; Ling C; Crosby EJ; Hartman ZC; Simond AM; Chodosh LA; Rennhack JP; Andrechek ER; Ozcelik J; Hallett M; Mills GB; Cardiff RD; Gray JW; Griffith OL; Muller WJ
Oncogene; 2016 Nov; 35(47):6053-6064. PubMed ID: 27157621
[TBL] [Abstract][Full Text] [Related]
8. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
9. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
10. Co-opted integrin signaling in ErbB2-induced mammary tumor progression.
Carraway KL; Sweeney C
Cancer Cell; 2006 Aug; 10(2):93-5. PubMed ID: 16904607
[TBL] [Abstract][Full Text] [Related]
11. Novel role for PDEF in epithelial cell migration and invasion.
Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
[TBL] [Abstract][Full Text] [Related]
12. Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5.
Ward TM; Iorns E; Liu X; Hoe N; Kim P; Singh S; Dean S; Jegg AM; Gallas M; Rodriguez C; Lippman M; Landgraf R; Pegram MD
Oncogene; 2013 May; 32(19):2463-74. PubMed ID: 22751112
[TBL] [Abstract][Full Text] [Related]
13. c-Jun, a crucial molecule in metastasis of breast cancer and potential target for biotherapy.
Zhang Y; Pu X; Shi M; Chen L; Qian L; Song Y; Yuan G; Zhang H; Yu M; Hu M; Shen B; Guo N
Oncol Rep; 2007 Nov; 18(5):1207-12. PubMed ID: 17914574
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S
Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183
[TBL] [Abstract][Full Text] [Related]
15. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
[TBL] [Abstract][Full Text] [Related]
16. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
[TBL] [Abstract][Full Text] [Related]
18. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
19. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.
Floris A; Luo J; Frank J; Zhou J; Orrù S; Biancolella M; Pucci S; Orlandi A; Campagna P; Balzano A; Ramani K; Tomasi ML
J Exp Clin Cancer Res; 2019 Jan; 38(1):4. PubMed ID: 30611309
[TBL] [Abstract][Full Text] [Related]
20. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
